Dimerix Limited (ASX:DXB)
Australia · Delayed Price · Currency is AUD 0.2100
+0.0050 (2.44%)
Oct 21, 2026, 4:10 PM AEDT
Dimerix Market Cap
Dimerix has a market cap or net worth of 126.08 million as of October 21, 2026. It is the 26,086th most valuable company in the world and the 556th biggest in Australia. Its market cap has decreased by 59.21% in one year.
Market Cap
126.08M
Enterprise Value
110.16M
Revenue
6.35M
Global Rank
Country Rank
#556 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since July 6, 2015, Dimerix's market cap has increased from 13.24M to 126.08M, an increase of 852.55%. That is a compound annual growth rate of 22.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2026 | 126.08M | -61.82% |
| Dec 31, 2025 | 330.22M | 74.10% |
| Dec 31, 2024 | 189.67M | 117.15% |
| Dec 29, 2023 | 87.35M | 87.74% |
| Dec 30, 2022 | 46.53M | -40.82% |
| Dec 31, 2021 | 78.61M | 69.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BLS Pharmaceuticals | 238.37M |
| Orthocell | 177.06M |
| Actinogen Medical | 177.00M |
| Paradigm Biopharmaceuticals | 146.80M |
| Nyrada | 106.46M |
| Island Pharmaceuticals | 99.19M |
| Recce Pharmaceuticals | 88.67M |
| LTR Pharma | 86.58M |